Ganciclovir structure
|
Common Name | Ganciclovir | ||
---|---|---|---|---|
CAS Number | 82410-32-0 | Molecular Weight | 255.231 | |
Density | 1.8±0.1 g/cm3 | Boiling Point | 657.0±65.0 °C at 760 mmHg | |
Molecular Formula | C9H13N5O4 | Melting Point | 250°C | |
MSDS | Chinese USA | Flash Point | 351.1±34.3 °C | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of GanciclovirGanciclovir is a potent herpes simplex virus (HSV)inhibitor, including cytomegalovirus (CMV), with an IC50 of 5.2 μM for feline herpesvirus type-1 (FHV-1). |
Name | ganciclovir |
---|---|
Synonym | More Synonyms |
Description | Ganciclovir is a potent herpes simplex virus (HSV)inhibitor, including cytomegalovirus (CMV), with an IC50 of 5.2 μM for feline herpesvirus type-1 (FHV-1). |
---|---|
Related Catalog | |
Target |
IC50: 5.2 μM (FHV-1)[1] |
In Vitro | Ganciclovir is an acyclic deoxyguanosine analog structurally similar to acyclovir but with superior activity against CMV. The median ganciclovir concentration required to inhibit viral replication by 50 percent is 2.15 mumol versus 72 mumol for acyclovir[2].The primary mechanism of ganciclovir action against CMV is inhibition of the replication of viral DNA by ganciclovir-5'-triphosphate (ganciclovir-TP). This inhibition includes a selective and potent inhibition of the viral DNA polymerase.Ganciclovir is metabolized to the triphosphate form by primarily three cellular enzymes: a deoxyguanosine kinase induced by CMV-infected cells; guanylate kinase; and phosphoglycerate kinase[3]. |
In Vivo | In adult rats, the intracochlear diffusion of ganciclovir is shown to achieve the same concentration as in blood. In gestating mice, transplacental diffusion is observed, with a fetal-to-maternal blood ratio of 0.5. In newborn mice, the plasma concentration profile of ganciclovir shows a peak at 2 h followed by a gradual decrease. In adult mice, the concentration peaked at 1 h, but becomes undetectable by 2 h after injection. Counts of white blood cells, red blood cells and platelets decreases significantly in ganciclovir-treated newborn mice[4]. |
Animal Admin | Rats: Two albino rats non-immunized for MCMV are used in the study. After being weighed, two adult rats undergo peritoneal injections. The first rat receives 50 mg/kg of ganciclovir twice a day (i.e. 100 mg/kg/day), for a total of 3 days or 6 injections. The second rat is used as a negative control and received intraperitoneal injections of glucose solution. After the 6th injection, the two rats are sacrified; blood and perilymphatic fluids are collected for analysis[4]. Mice: Non-inbred Oncins France 1 (OF1) mice are used in the study. Ganciclovir is diluted in 5% glucose serum to a concentration of 5 mg/mL and administered intraperitoneally in newborn mice at a dose of 50 mg/kg twice a day. Five injections are administered in total[4]. |
References |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 657.0±65.0 °C at 760 mmHg |
Melting Point | 250°C |
Molecular Formula | C9H13N5O4 |
Molecular Weight | 255.231 |
Flash Point | 351.1±34.3 °C |
Exact Mass | 255.096756 |
PSA | 139.28000 |
LogP | -3.62 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.761 |
Storage condition | 2-8°C |
Water Solubility | 0.1 M HCl: 10 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H360 |
Precautionary Statements | P201-P280-P308 + P313 |
Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R46;R60;R61 |
Safety Phrases | S53-S36/37/39-S45 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | MF8407000 |
HS Code | 2933990090 |
Precursor 9 | |
---|---|
DownStream 8 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
J. Virol. 89(8) , 4636-44, (2015) DNA polymerases of the Herpesviridae and bacteriophage RB69 belong to the α-like DNA polymerase family. In spite of similarities in structure and function, the RB69 enzyme is relatively resistant to f... |
|
Thymidine kinase gene delivery using curcumin loaded peptide micelles as a combination therapy for glioblastoma.
Pharm. Res. 32(2) , 528-37, (2015) The effect of the combination therapy of curcumin and the herpes simplex virus thymidine kinase (HSVtk) gene using R7L10 as a carrier was evaluated in a glioblastoma animal model.Curcumin was loaded i... |
|
Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection.
J. Exp. Med. 211(6) , 1197-213, (2014) Competition for iron influences host-pathogen interactions. Pathogens secrete small iron-binding moieties, siderophores, to acquire host iron. In response, the host secretes siderophore-binding protei... |
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]- |
Vitrasert |
Gancyclovir |
HHEMG |
T56 BN DN FN HNJ D1OY1Q1Q GZ IQ |
MFCD00870588 |
Ganciclovir |
Cymevene |
bwb759u |
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-3,9-dihydro-6H-purin-6-one |
2'-ndg |
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- |
DHPG |
biolf62 |
T56 BN DN FVM INJ B1OY1Q1Q HZ |
cymevan |
Cytovene |
1,3-Propanediol, 2-[(2,3-dihydro-6-hydroxy-2-imino-9H-purin-9-yl)methoxy]- |
2-Amino-9-{[(1,3-dihydroxy-2-propanyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one |
BW B759U |
bw-759u |
GVC |
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one |
2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one |
2-[(6-Hydroxy-2-imino-2,3-dihydro-9H-purin-9-yl)methoxy]-1,3-propanediol |
bw-759 |